Transitioning from weight loss to maintenance Determining goal weight achievement: Lost 10-12% body weight (cagrilintide alone) Lost 15-25% body weight (CagriSema) Weight stable for 4-8 weeks Satisfied with current weight Ready to focus on maintenance Maintenance dose options comparison: Option 1: Continue same dose Keep cagrilintide at 2.4mg weekly Ensures no regain Most conservative approach Highest cost Option 2: Reduce dose slightly Decrease to 1.8-2.0mg weekly Monitor weight for 4 weeks If stable, maintain If gaining, increase back 20-25% cost savings Option 3: Try every 10 days Instead of weekly, inject every 10 days Effectively 30% dose reduction Some maintain weight this way Requires close monitoring Recommendation: Try Option 2 first (reduce to 1.8-2.0mg)
The clinical use of peptides for arthritis is based on mechanistic rationale and extrapolation from tissue healing studies, supported by physician observation of clinical outcomes
The complex proteins in your skin, such as collagen and elastin, need peptides for carrying out their normal functions
Cagrilintide alone produced about 10.8% weight loss at 26 weeks in monotherapy (Lau et al., 2021)
Those with Wilson's disease or copper metabolism disorders should avoid GHK-CU entirely
Research specifically on the combined three-peptide formulation is limited
